[1] SUNG H,FERLAY J,SIEGEL R L,et al.Global cancer statistics 2020:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J].CA Cancer J Clin,2021,71(3):209-249.
[2] XIA C F,DONG X S,LI H,et al.Cancer statistics in China and United States,2022:profiles,trends,and determinants[J].CMJ,2022,135(5):584-590.
[3] VILLANUEVA A.Hepatocellular carcinoma[J].N Engl J Med,2019,380(15):1450-1462.
[4] TAVAKOLI A,MONAVARI S H,SOLAYMANI-MOHAMMADI F,et al.Association between epstein-barr virus infection and gastric cancer:a systematic review and meta-analysis[J].BMC Cancer,2020,20(1):493.
[5] YAGHOOBI M,MCNABB-BALTAR J,BIJARCHI R,er al.What is the quantitative risk of gastric cancer in the first-degree relatives of patients? A meta-analysis[J].World J Gastroenterol,2017,23(13):2435-2442.
[6] IARC Working Group on the Evaluation of Carcinogenic Risks to Humans.Biological agents[J].IARC Monogr Eval Carcinog Risks Hum,2012,100(Pt B):1-441.
[7] GBD 2019 Hepatitis B Collaborators.Global,regional,and national burden of hepatitis B,1990-2019:a systematic analysis for the Global Burden of Disease Study 2019[J].Lancet Gastroenterol Hepatol,2022,7(9):796-829.
[8] MASON A,WICK M,WHITE H,et al.Hepatitis B virus replication in diverse cell types during chronic hepatitis B virus infection[J].Hepatology,1993,18(4):781-789.
[9] BEASLEY R P,HWANG L Y,LIN C C,et al.Hepatocellular carcinoma and hepatitis B virus.A prospective study of 22 707 men in Taiwan[J].Lancet,1981,2(8256):1129-1133.
[10] VILLENEUVE J P,DESROCHERS M,INFANTE-RIVARD C,et al.A long-term follow-up study of asymptomatic hepatitis B surface antigen-positive carriers in Montreal[J].Gastroenterology,1994,106(4):1000-1005.
[11] RIBES J,CLÈRIES R,RUBIÓ A,et al.Cofactors associated with liver disease mortality in an HBsAg-positive Mediterranean cohort:20 years of follow-up[J].Int J Cancer,2006,119(3):687-694.
[12] CHEN C J,YANG H I,et al.REVEAL-HBV Study Group.Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level[J].JAMA,2006,295(1):65-73.
[13] EL-SERAG H B.Epidemiology of viral hepatitis and hepatocellular carcinoma[J].Gastroenterology,2012,142(6):1264-1273,e1.
[14] LEVRERO M,ZUCMAN-ROSSI J.Mechanisms of HBV-induced hepatocellular carcinoma[J].J Hepatol,2016,64(1 Suppl):S84-S101.
[15] MCMAHON B J,NOLEN L D,SNOWBALL M,et al.HBV Genotype:a significant risk factor in determining which patients with chronic HBV infection should undergo surveillance for HCC:The hepatitis B alaska study[J].Hepatology,2021,74(6):2965-2973.
[16] CHAN H L,HUI A Y,WONG M L,et al.Genotype C hepatitis B virus infection is associated with an increased risk of hepatocellular carcinoma[J].Gut,2004,53(10):1494-1498.
[17] WUNGUCD K,ARIYANTO F C,PRABOWO G I,et al.Meta-analysis:association between hepatitis B virus preS mutation and hepatocellular carcinoma risk[J].J Viral Hepat,2021,28(1):61-71.
[18] LIU S,ZHANG H,GU C,et al.Associations between hepatitis B virus mutations and the risk of hepatocellular carcinoma:a meta-analysis[J].J Natl Cancer Inst,2009,101(15):1066-1082.
[19] LEE D,LYU H,CHUNG Y H,et al.Genomic change in hepatitis B virus associated with development of hepatocellular carcinoma[J].World J Gastroenterol,2016,22(23):5393-5399.
[20] JONG H L,KWANG H H,JAE M L,et al.Impact of hepatitis B virus(HBV) X gene mutations on hepatocellular carcinoma development in chronic HBV infection[J].Clin Vaccine Immunol,2011,18(6):914-921.
[21] SU F H,LE T N,MUO C H,et al.Chronic hepatitis B virus infection associated with increased colorectal cancer risk in Taiwanese population[J].Viruses,2020,12(1):97.
[22] KAMIZ A B,SU F H,WANG W C,et al.Chronic hepatitis infection is associated with extrahepatic cancer development:a nationwide population-based study in Taiwan[J].BMC Cancer,2016,16(1):861.
[23] LIU T,LI W Q,ZHANG Y C,et al.Associations between hepatitis B virus infection and risk of colorectal Cancer:a population-based prospective study[J].BMC Cancer,2021,21(1):1119.
[24] SONG C,LÜ J,LIU Y,et al.Associations between hepatitis B virus infection and risk of all cancer types[J].JAMA Netw Open,2019,2(6):e195718.
[25] DARVISHIAN M,BUTT-ZAHID A,WONG S,et al.Elevated risk of colorectal,liver,and pancreatic cancers among HCV,HBV and/or HIV(co)infected individuals in a population based cohort in Canada[J].Ther Adv Med Oncol,2021,13:1758835921992987.
[26] AN J Y,KIM J W,SHIM J H,et al.Chronic hepatitis B infection and non-hepatocellular cancers:a hospital registry-based,case-control study[J].PLoS One,2018,13(3):e0193232.
[27] HONG C Y,SINN D H,KANG D,et al.Incidence of extrahepatic cancers among individuals with chronic hepatitis B or C virus infection:a nationwide cohort study[J].J Viral Hepat,2020,27(9):896-903.
[28] WEI X L,QIU M Z,JIN Y,et al.Hepatitis B virus infection is associated with gastric cancer in China:an endemic area of both diseases[J].Br J Cancer,2015,112(7):1283-1290.
[29] MAHALE P,ENGELS E A,KOSHIOL J.Hepatitis B virus infection and the risk of cancer in the elderly US population[J].Int J Cancer,2019,144(3):431-439.
[30] SPRADLING P R,XING J.for the Chronic Hepatitis Cohort Study(CHeCS) Investigators.Incidence of malignancies among patients with chronic hepatitis B in US health care organizations,2006-2018[J].J Infect Dis,2022,226(5):896-900.
[31] TIAN T,SONG C,JIANG L F,et al.Hepatitis B virus infection and the risk of cancer among the Chinese population[J].Int J Cancer,2020,147(11):3075-3084.
[32] LIU T,SONG C H,ZHANG Y C,et al.Hepatitis B virus infection and the risk of gastrointestinal cancers among Chinese population:a prospective cohort study[J].Int J Cancer,2020,147(11):3075-3084.
[33] WANG H,CHEN X Z,CHEN X L,et al.Associations between hepatitis B virus exposure and the risk of extrahepatic digestive system cancers:a hospital-based,case-control study(SIGES)[J].Cancer Med,2021,10(11):3741-3755.
[34] HOEFS J C,RENNER L G,ASHCAVAI M,et al.Hepatitis B surface antigen in pancreatic and biliary secretions[J].Gastroenterology,1980,79(2):191-194.
[35] YOSHIMURA M,SAKURAI I,SHIMODA T,et al.Detection of HBsAg in the pancreas[J].Acta Pathol Jpn,1981,31(4):711-717.
[36] HASSAN M M,LI D,El-DEEB A S,et al,Abbruzzese JL.Association between hepatitis B virus and pancreatic cancer[J].J Clin Oncol,2008,26(28):4557-4562.
[37] ILOBEJE U H,YANG H I,JEN C L,et al.Risk of pancreatic cancer in chronic hepatitis B virus infection:data from the REVEAL-HBV cohort study[J].Liver Int,2010,30(3):423-429.
[38] KRULL A S,INOUE M,SAWADA N,et al.Hepatitis B and C virus infection and risk of pancreatic cancer:A population-based cohort study (JPHC Study Cohort II)[J].Cancer Epidemiol Biomarkers Prev,2016,25(3):555-557.
[39] ANDERSEN E S,OMLAND L H.DANVIR Cohort Study.Risk of all-type cancer,hepatocellular carcinoma,non-Hodgkin lymphoma and pancreatic cancer in patients infected with hepatitis B virus[J].J Viral Hepat,2015,22(10):828-834.
[40] TANG J,SHARMA R,LAMERATO L,et al.Is previous exposure to hepatitis B a risk factor for pancreatic cancer or hepatocellular carcinoma?[J].J Clin Gastroenterol,2014,48(8):729-733.
[41] HUANG J,MAGNUSSON M,Törner A,et al.Risk of pancreatic cancer among individuals with hepatitis C or hepatitis B virus infection:a nationwide study in Sweden[J].Br J Cancer,2013,109(11):2917-2923.
[42] BEN Q,LI Z,LIU C,et al.Hepatitis B virus status and risk of pancreatic ductal adenocarcinoma:a case-control study from China[J].Pancreas,2012,41(3):435-440.
[43] WOO S M,JOO J,LEE W J,et al.Risk of pancreatic cancer in relation to ABO blood group and hepatitis C virus infection in Korea:a case-control study[J].J Korean Med Sci,2013,28(2):247-251.
[44] WANG D S,CHEN D L,REN C,et al.ABO blood group,hepatitis B viral infection and risk of pancreatic cancer[J].Int J Cancer,2012,131(2):461-468.
[45] ZHU F,LI H R,DU G N,et al.Chronic hepatitis B virus infection and pancreatic cancer:a case-control study in southern China[J].Asian Pac J Cancer Prev,2011,12(6):1405-1408.
[46] LIU X,ZHANG Z H,JIANGN F.Hepatitis B virus infection increases the risk of pancreatic cancer:a meta-analysis[J].Scand J Gastroenterol,2021,56(3):252-258. |
